Global Health

A new COVID vaccine targets the original strain and Omicron. Which countries have approved it?

Person receiving a vaccination from a nurse.

Trials of the bivalent COVID jab showed an eight-fold rise in neutralizing antibodies against Omicron. Image: Unsplash/CDC

Manal Mohammed
Lecturer, University of Westminster
Share:
Our Impact
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Global Health

Visualisation of the Omicron structure.
BA.1 was the first omicron subvariant, but BA.5 is now the dominant variant in the UK and globally. Image: Unsplash/JINZHOU LIN

Discover

What is the World Economic Forum doing about fighting pandemics?

Have you read?
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Global HealthPandemic Preparedness and ResponseVaccination
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

New research links nanoplastics to Parkinson’s and some types of dementia

Janosch Heller

December 5, 2023

1:42

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum